KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Co-Diagnostics (CODX) Net Margin (2017 - 2025)

Historic Net Margin for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to 4049.27%.

  • Co-Diagnostics' Net Margin fell 25368900.0% to 4049.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 6336.27%, marking a year-over-year decrease of 57723500.0%. This contributed to the annual value of 961.37% for FY2024, which is 4426800.0% down from last year.
  • As of Q3 2025, Co-Diagnostics' Net Margin stood at 4049.27%, which was down 25368900.0% from 4745.02% recorded in Q2 2025.
  • Co-Diagnostics' Net Margin's 5-year high stood at 51.61% during Q1 2022, with a 5-year trough of 14983.53% in Q1 2025.
  • Moreover, its 5-year median value for Net Margin was 412.82% (2023), whereas its average is 2237.72%.
  • As far as peak fluctuations go, Co-Diagnostics' Net Margin soared by 42228500bps in 2024, and later plummeted by -129931600bps in 2025.
  • Quarter analysis of 5 years shows Co-Diagnostics' Net Margin stood at 36.75% in 2021, then plummeted by -4353bps to 1563.02% in 2022, then surged by 74bps to 412.82% in 2023, then crashed by -1689bps to 7387.37% in 2024, then skyrocketed by 45bps to 4049.27% in 2025.
  • Its last three reported values are 4049.27% in Q3 2025, 4745.02% for Q2 2025, and 14983.53% during Q1 2025.